Pages that link to "Q24681342"
Jump to navigation
Jump to search
The following pages link to Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL (Q24681342):
Displaying 50 items.
- The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88 (Q24293739) (← links)
- Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development (Q24336188) (← links)
- Lessons from mathematically modeling the NF-κB pathway (Q27690748) (← links)
- Regulatory roles of the tumor necrosis factor receptor BCMA. (Q30422814) (← links)
- Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas (Q33325701) (← links)
- APRIL is overexpressed in cancer: link with tumor progression (Q33418752) (← links)
- Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL (Q33559757) (← links)
- Role of the translocation partner in protection against AID-dependent chromosomal translocations (Q33591714) (← links)
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma. (Q33621610) (← links)
- Pediatric pulmonary Hodgkin lymphoma: analysis of 10 years data from a single center. (Q33767692) (← links)
- Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies (Q33889168) (← links)
- B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells (Q33946456) (← links)
- Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment (Q34235750) (← links)
- Innate signaling networks in mucosal IgA class switching (Q34614189) (← links)
- Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. (Q34624625) (← links)
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment (Q34628392) (← links)
- The biology of intestinal immunoglobulin A responses (Q34673861) (← links)
- Different Donor Cell Culture Methods Can Influence the Developmental Ability of Cloned Sheep Embryos (Q35751187) (← links)
- Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. (Q36016378) (← links)
- Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function (Q36630985) (← links)
- Clinical targeting of the TNF and TNFR superfamilies (Q36762882) (← links)
- High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency (Q36800138) (← links)
- Lymphoma microenvironment: culprit or innocent? (Q36959865) (← links)
- B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention (Q36990979) (← links)
- Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell (Q37004635) (← links)
- B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation (Q37009908) (← links)
- APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. (Q37035836) (← links)
- Crosstalk via the NF-kappaB signaling system (Q37178526) (← links)
- A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation (Q37201980) (← links)
- Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity (Q37239051) (← links)
- Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment (Q37271829) (← links)
- The BLyS family: toward a molecular understanding of B cell homeostasis (Q37335169) (← links)
- Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma (Q37345560) (← links)
- The biology of Hodgkin's lymphoma (Q37349652) (← links)
- Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma. (Q37401508) (← links)
- Involvement of BAFF and APRIL in Resistance to Apoptosis of Acute Myeloid Leukemia. (Q37427930) (← links)
- The Epstein-Barr virus and the pathogenesis of lymphoma. (Q38258049) (← links)
- The role of T cells in the microenvironment of Hodgkin lymphoma (Q38576547) (← links)
- Targeting B-cell maturation antigen in multiple myeloma (Q38586922) (← links)
- Prognostic Biomarkers for Hodgkin Lymphoma (Q38588503) (← links)
- Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma (Q38596350) (← links)
- Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. (Q38755707) (← links)
- WNT5A: a motility-promoting factor in Hodgkin lymphoma. (Q38766162) (← links)
- Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma (Q38868904) (← links)
- New monoclonal antibodies on the horizon in multiple myeloma (Q39137696) (← links)
- Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma (Q39709396) (← links)
- Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway (Q39847568) (← links)
- Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation (Q39858777) (← links)
- B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells (Q39973901) (← links)
- Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma (Q40042049) (← links)